Neurocrine Biosciences (NBIX) Non Operating Income: 2009-2019
Historic Non Operating Income for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2019 value amounting to -$25.7 million.
- Neurocrine Biosciences' Non Operating Income fell 9.38% to -$14.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$36.4 million, marking a year-over-year decrease of 0.16%. This contributed to the annual value of -$25.7 million for FY2019, which is 70.99% down from last year.
- Per Neurocrine Biosciences' latest filing, its Non Operating Income stood at -$25.7 million for FY2019, which was down 70.99% from -$15.1 million recorded in FY2018.
- Neurocrine Biosciences' Non Operating Income's 5-year high stood at $6.3 million during FY2016, with a 5-year trough of -$25.7 million in FY2019.
- For the 3-year period, Neurocrine Biosciences' Non Operating Income averaged around -$17.3 million, with its median value being -$15.1 million (2018).
- Its Non Operating Income has fluctuated over the past 5 years, first spiked by 36.29% in 2015, then tumbled by 277.98% in 2017.
- Over the past 5 years, Neurocrine Biosciences' Non Operating Income (Yearly) stood at $5.3 million in 2015, then rose by 19.14% to $6.3 million in 2016, then tumbled by 277.98% to -$11.2 million in 2017, then slumped by 34.64% to -$15.1 million in 2018, then tumbled by 70.99% to -$25.7 million in 2019.